13.96EUR+3.41%Mkt Cap: 353.85M EURP/E: 22.54Last update: 2026-05-29
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company of…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap353.85M EUR
Enterprise Value370.38M EUR
Revenue (TTM)111.05M EUR
Gross Profit77.80M EUR
Net Income (TTM)17.41M EUR
Revenue/Share4.158 EUR
Last Price13.96 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees246
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI0009010912
Valuation
P/E (Trailing)22.54
P/E (Forward)14.44
PEG6.37
EV/EBITDA15.43
EV/Revenue3.34
P/S3.36
P/B3.25
EPS (TTM)0.59
EPS (Forward)0.97
52W Range
13.264% of range29.45
52W High29.45 EUR
52W Low13.26 EUR
Profitability
Gross Margin70.94%
Oper. Margin8.43%
EBITDA Margin21.61%
Profit Margin15.88%
ROE15.18%
ROA11.56%
Growth
Revenue Growth4.60%
Earnings Growth-41.40%
Cash Flow & Leverage
Operating CF30.23M EUR
CapEx (TTM)4.18M EUR
FCF Margin12.47%
FCF Yield3.91%
Net Debt-10.60M EUR
Net Debt/EBITDA-0.44
Balance Sheet
Debt/Equity0.10
Current Ratio2.27
Quick Ratio1.76
Book Value/Sh4.312 EUR
Cash/Share0.7880 EUR
Dividends
Fwd Div Rate0.4000 EUR
Trail. Div Rate0.4400 EUR
Div. Yield2.04%
5Y Avg Yield1.21%
Payout Ratio67.85%
Ex-Div DateApr 11, 2025
Pay Date—
Splits
Last Split2:1
Split DateMar 20, 2020
Analyst Consensus
Rating—
Target (Mean)19.38 EUR
Target Range15.00 EUR – 23.50 EUR
# Analysts4
Ownership
Shares Out.26.61M
Float26.72M
Insiders3.23%
Institutions60.79%
Technical
SMA 5016.21 (-13.9%)
SMA 20020.64 (-32.4%)
Beta0.85
S&P 52W Chg27.94%
Avg Vol (30d)86.27K
Avg Vol (10d)40.03K
Technical Indicators
RSI (14)31.9
MACD-0.6472
MACD Signal-0.7834
MACD Hist.+0.1362
BB Upper14.29 EUR
BB Middle13.85 EUR
BB Lower13.40 EUR
BB Width6.38%
ATR (14)0.4903 EUR
Vol Ratio (20d)1.70x